|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
DE60143520D1
(de)
|
2000-03-24 |
2011-01-05 |
Methylgene Inc |
Inhibitoren der histon-deacetylase
|
|
WO2002074298A1
(en)
|
2001-03-21 |
2002-09-26 |
Ono Pharmaceutical Co., Ltd. |
Il-6 production inhibitors
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
CA2463821A1
(en)
|
2001-11-01 |
2003-05-08 |
Janssen Pharmaceutica N.V. |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7375228B2
(en)
|
2003-03-17 |
2008-05-20 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US8227636B2
(en)
|
2004-04-05 |
2012-07-24 |
Merck Hdac Research, Llc |
Histone deacetylase inhibitor prodrugs
|
|
SG171690A1
(en)
|
2005-03-22 |
2011-06-29 |
Harvard College |
Treatment of protein degradation disorders
|
|
WO2007022638A1
(en)
|
2005-08-26 |
2007-03-01 |
Methylgene Inc. |
Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
|
|
AU2007345292B2
(en)
|
2006-02-14 |
2013-10-31 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
US8304451B2
(en)
|
2006-05-03 |
2012-11-06 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
WO2007144341A1
(en)
|
2006-06-12 |
2007-12-21 |
Vrije Universiteit Brussel |
Differentiation of rat liver epithelial cells into hepatocyte-like cells
|
|
ES2288802B1
(es)
|
2006-07-07 |
2008-12-16 |
Universidad De Granada |
Nuevos derivados de ftalimida como inhibidores de las histonas desacetilasas.
|
|
JP5563300B2
(ja)
|
2006-09-11 |
2014-07-30 |
キュリス，インコーポレイテッド |
亜鉛結合部分を含むチロシンキナーゼインヒビター
|
|
US8778410B2
(en)
|
2008-02-19 |
2014-07-15 |
Earnest Medicine Co., Ltd. |
Oral or enteral composition useful for recovery of physical functions
|
|
CN102164888B
(zh)
|
2008-07-23 |
2015-06-03 |
哈佛大学校长及研究员协会 |
脱乙酰酶抑制剂和其用途
|
|
EP2429987A4
(en)
|
2009-05-15 |
2012-10-03 |
Korea Res Inst Chem Tech |
AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
WO2011084991A2
(en)
|
2010-01-08 |
2011-07-14 |
President And Fellows Of Harvard College |
Fluorinated hdac inhibitors and uses thereof
|
|
PL2526093T3
(pl)
|
2010-01-22 |
2017-02-28 |
Acetylon Pharmaceuticals, Inc. |
Odwrócone związki amidowe jako inhibitory deacetylazy białkowej oraz sposoby ich stosowania
|
|
AU2011255281A1
(en)
|
2010-05-21 |
2013-01-10 |
Sloan-Kettering Institute For Cancer Research |
Selective HDAC inhibitors
|
|
WO2012018499A2
(en)
|
2010-08-05 |
2012-02-09 |
Acetylon Pharmaceuticals |
Specific regulation of cytokine levels by hdac6 inhibitors
|
|
WO2012068109A2
(en)
|
2010-11-16 |
2012-05-24 |
Acetylon Pharmaceuticals |
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
|
|
EP2734500A4
(en)
|
2011-07-20 |
2015-04-08 |
Gen Hospital Corp |
SELECTIVE HISTONDEACETYLASE-6 INHIBITORS FOR THE TREATMENT OF BONE DISORDERS
|
|
EP2839037B1
(en)
|
2012-04-19 |
2018-12-26 |
Acetylon Pharmaceuticals, Inc. |
Biomarkers to identify patients that will respond to treatment and treating such patients
|
|
HK1213471A1
(zh)
|
2012-10-12 |
2016-07-08 |
The Trustees Of The University Of Pennsylvania |
作為蛋白脫乙酰基酶抑制劑的嘧啶羥基酰胺化合物及其使用方法
|
|
US9145412B2
(en)
|
2012-11-02 |
2015-09-29 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC1 and HDAC2 inhibitors
|
|
JP2016511237A
(ja)
|
2013-02-01 |
2016-04-14 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
選択的ｈｄａｃ３阻害剤
|
|
US9139583B2
(en)
|
2013-02-01 |
2015-09-22 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC3 inhibitors
|
|
US20140357512A1
(en)
|
2013-06-03 |
2014-12-04 |
Acetylon Pharmaceuticals, Inc. |
Histone deacetylase (hdac) biomarkers in multiple myeloma
|
|
WO2015042418A1
(en)
|
2013-09-20 |
2015-03-26 |
Acetylon Pharmaceuticals, Inc. |
Treatment of diseases caused by abnormal lymphocyte function with an hdac6 inhibitor
|
|
JP6626437B2
(ja)
|
2013-10-08 |
2019-12-25 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
ヒストンデアセチラーゼ阻害剤とＨｅｒ２阻害剤またはＰＩ３Ｋ阻害剤のいずれかの組み合わせ
|
|
WO2015054474A1
(en)
|
2013-10-10 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
|
|
EP3054954A4
(en)
*
|
2013-10-10 |
2017-12-13 |
Acetylon Pharmaceuticals, Inc. |
Hdac inhibitors, alone or in combination with btk inhibitors, for treating non-hodgkin's lymphoma
|
|
JP6584391B2
(ja)
|
2013-10-10 |
2019-10-02 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
非ホジキンリンパ腫を治療するための、ｈｄａｃ阻害剤単独またはｐｉ３ｋ阻害剤との組み合わせ
|
|
EA201690753A1
(ru)
|
2013-10-11 |
2016-07-29 |
Эситайлон Фармасьютикалз, Инк. |
Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
|
|
JP2016534069A
(ja)
|
2013-10-24 |
2016-11-04 |
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ |
Ｈｄａｃ６阻害剤での多嚢胞性疾患の治療
|
|
BR112016012561A2
(pt)
|
2013-12-03 |
2017-08-08 |
Acetylon Pharmaceuticals Inc |
Combinações de inibidores da histona desacetilase e fármacos imunomoduladores
|
|
EP3084446B1
(en)
|
2013-12-20 |
2022-12-14 |
Acetylon Pharmaceuticals, Inc. |
Histone deacetylase 6 (hdac6) biomarkers in multiple myeloma
|
|
US9464073B2
(en)
|
2014-02-26 |
2016-10-11 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
|
|
US20150359794A1
(en)
|
2014-06-13 |
2015-12-17 |
Buck Institute For Research On Aging |
Impairment of the large ribosomal subunit protein rpl24 by depletion or acetylation
|
|
AU2015288060A1
(en)
|
2014-07-07 |
2017-02-09 |
Acetylon Pharmaceuticals, Inc. |
Treatment of leukemia with histone deacetylase inhibitors
|
|
WO2016057779A2
(en)
|
2014-10-08 |
2016-04-14 |
Acetylon Pharmaceuticals, Inc. |
Induction of gata2 by hdac1 and hdac2 inhibitors
|
|
US20160158231A1
(en)
|
2014-12-05 |
2016-06-09 |
Vib Vzw |
Pyrimidine hydroxy amide compounds for treating peripheral neuropathy
|
|
WO2016087950A1
(en)
|
2014-12-05 |
2016-06-09 |
University of Modena and Reggio Emilia |
Combinations of histone deacetylase inhibitors and bendamustine for use in the treatment of lymphoma
|
|
SG11201704759QA
(en)
|
2014-12-12 |
2017-07-28 |
Regenacy Pharmaceuticals Llc |
Piperidine derivatives as hdac1/2 inhibitors
|
|
WO2016168647A1
(en)
|
2015-04-17 |
2016-10-20 |
Acetylon Pharmaceuticals Inc. |
Treatment of neuroblastoma with histone deacetylase inhibotrs
|
|
US10272084B2
(en)
|
2015-06-01 |
2019-04-30 |
Regenacy Pharmaceuticals, Llc |
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
|
|
ES2769255T3
(es)
|
2015-06-08 |
2020-06-25 |
Acetylon Pharmaceuticals Inc |
Métodos para fabricar inhibidores de la proteína desacetilasa
|